TOI
The Oncology Institute, Inc.
$6.20
+0.16%
2026-08-11
About The Oncology Institute, Inc.
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Key Fundamentals
Forward P/E
-36.81
EPS (TTM)
$-0.35
ROE
-4132.2%
Revenue Growth (YoY)
41.2%
Profit Margin
-8.0%
Beta
0.39
Market Cap
$588.9M
Avg Volume (10D)
2.5M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$7.05
60D Low
$3.86
Avg Volume
1.9M
Latest Close
$6.20
Get breakout alerts for TOI
Sign up for Breakout Scanner to receive daily notifications when TOI triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
The Oncology Institute, Inc. (TOI) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors TOI daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. TOI operates in the Healthcare sector within the Medical Care Facilities industry. Data is provided for informational purposes only and does not constitute financial advice.